Fierce Pharma June 24, 2024
Following last week’s news that generic drugmaker Hikma is acquiring parts of Xellia’s assets in the U.S., the Danish drugmaker has unveiled plans for a fresh round of layoffs.
In connection with the sale of the company’s Bedford plant on the outskirts of Cleveland, Ohio, to Hikma, Xellia said it’s cutting 247 positions in the U.S. Of the affected staffers, 214 work at the Bedford facility, Xellia said in a Worker Adjustment and Retraining Notification (WARN) alert sent to the state.
The round of cuts will kick off in August and cover multiple roles at the company, including analytical chemists, aseptic operators, automation engineers, IT technicians and managerial positions.
The latest layoff round marks the second for Xellia this year.
...Today's Sponsors
Today's Sponsor